Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal luminal osmotic gradient is a physiological parameter representing the osmotic pressure difference between the gut lumen and the interstitial fluid, primarily regulated by the concentration of electrolytes and non-absorbable solutes (NIH, 2021). It serves as a primary therapeutic target for osmotic laxatives, such as polyethylene glycol and magnesium salts, which work by increasing the solute concentration in the lumen to draw in or retain water (StatPearls, 2023). This increase in luminal water volume softens the stool and distends the intestinal wall, triggering peristaltic movements to facilitate evacuation. Beyond treating constipation, manipulating this gradient is vital for bowel preparation before surgical or endoscopic procedures and for managing hepatic encephalopathy by trapping ammonia in the gut (American Journal of Gastroenterology, 2021). Maintaining this gradient is essential for normal fluid homeostasis, and its disruption can lead to either constipation (excessive water reabsorption) or osmotic diarrhea (excessive luminal water). However, excessive manipulation can lead to significant clinical challenges, including dehydration and systemic electrolyte imbalances, particularly in patients with underlying renal or cardiac conditions.
Osmotic agents increase the solute concentration in the intestinal lumen, creating an osmotic gradient that draws water into the bowel or prevents its absorption, thereby increasing stool volume and stimulating peristalsis (StatPearls, 2023; NIH, 2021).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal luminal osmotic gradient.